Pay in 4 interest-free payments of $6.09 Learn more
Ships within 48 hours · Estimated delivery Aug 24 - Aug 29
Both are synthetic 39-amino-acid incretin-receptor-agonist peptides, but Tirzepatide engages two receptors (GIPR, GLP-1R) while Retatrutide engages three (GIPR, GLP-1R, GCGR)
The long-term outcome phase (months 4-12) establishes final post-treatment baseline revealing maximum durable benefits maintained without ongoing GHK-Cu use
Cagrilintides Novel Mechanism of Action Cagrilintide functions as a long-acting analog of amylin, designed to replicate and enhance the hormones natural role in signaling fullness after meals
12 weeks 84 syringes Still within a single 100-count box
US$ 27.92
US$ 28.77
US$ 29.89
US$ 25.34
US$ 24.10
US$ 29.04
US$ 20.55
US$ 26.87
US$ 24.82
US$ 28.28
